<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[healthcare Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/healthcare.html;//www.verizon.com/]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to healthcare]]></description>
	<s:counts start="0" returned="20" found="42969" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Medicare Actuary's Reform Report, Part II]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/10001503/medicare-actuarys-reform-report-part-ii/]]></link>
		<description><![CDATA[The CMS actuary's report fueled new political controversy, but his contention that reform would threaten bankruptcy for a fifth of hospitals is doubtful. by Ken Terry]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 14 Dec 2009 16:01:50 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/actuary.html"><![CDATA[Actuary]]></category>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/content+management.html"><![CDATA[Content Management]]></category>
		<category domain="http://resources.bnet.com/topic/personal+finance.html"><![CDATA[Personal Finance]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
	</item>
	<item>
		<title><![CDATA[GSK's $15m fees data go online]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fde203e0e-e8ff-11de-a756-00144feab49a.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ GlaxoSmithKline paid close to $15m (£9m) in speaking and consulting fees to US doctors in the second quarter of this year, revealing the scale of commercial links to influential prescribers.GSK published on its website 121 pages listing more than 3,700 doctors who had received fees for work including speaking...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 14 Dec 2009 14:37:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fee.html"><![CDATA[Fee]]></category>
		<category domain="http://resources.bnet.com/topic/doctor.html"><![CDATA[Doctor]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/outsourcing.html"><![CDATA[Outsourcing]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/it+operations.html"><![CDATA[It Operations]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/outsourcing+%2526+subcontracting.html"><![CDATA[Outsourcing & Subcontracting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/health+%2526+healthcare.html"><![CDATA[Health & Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
	</item>
	<item>
		<title><![CDATA[Fat Cat Bankers Meet President Obama]]></title>
		<link><![CDATA[http://moneywatch.bnet.com/economic-news/blog/financial-decoder/fat-cat-bankers-meet-president-obama/1032/]]></link>
		<description><![CDATA["I did not run for office to be helping out a bunch of fat cat bankers on Wall Street"    -President Obama on CBS News "60 Minutes"        Fat Cat Wall Street bankers head to the White House for a meeting with...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 14 Dec 2009 08:07:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/barack+obama.html"><![CDATA[Barack Obama]]></category>
		<category domain="http://resources.bnet.com/topic/mortgages.html"><![CDATA[Mortgages]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare+reform.html"><![CDATA[Healthcare Reform]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/personal+finance.html"><![CDATA[Personal Finance]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/capital+structures.html"><![CDATA[Capital Structures]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jill+schlesinger.html"><![CDATA[Jill Schlesinger]]></category>
	</item>
	<item>
		<title><![CDATA[Berlusconi treated in hospital after being hit on face by missile]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F2718e8b4-e850-11de-8a02-00144feab49a.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ Silvio Berlusconi, Italy's prime minister, was in hospital last night after being injured by an object thrown from a crowd during a public appearance in Milan.Mr Berlusconi was hit in the face by the missile as he met supporters on the street after a rally of his People of...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 13 Dec 2009 18:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/hospital.html"><![CDATA[Hospital]]></category>
		<category domain="http://resources.bnet.com/topic/prime+minister.html"><![CDATA[Prime Minister]]></category>
		<category domain="http://resources.bnet.com/topic/attack.html"><![CDATA[Attack]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/media.html"><![CDATA[Media]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[Security]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/government+news.html"><![CDATA[Government News]]></category>
		<category domain="http://resources.bnet.com/topic/national+security.html"><![CDATA[National Security]]></category>
		<category domain="http://resources.bnet.com/topic/people.html"><![CDATA[People]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
	</item>
	<item>
		<title><![CDATA[The Historical Success of Growing Big Pharma from Small]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177903-the-historical-success-of-growing-big-pharma-from-small%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  So that roughly linear production of new drugs by Pfizer PFE, as shown in yesterday's chart, is not an anomaly. As the Bernard Munos article I've been talking about says: Surprisingly, nothing that companies have done in the past 60 years has affected their rates of...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 13 Dec 2009 12:18:38 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/derek+lowe.html"><![CDATA[Derek Lowe]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Cytori Therapeutics: Natural Celution for Breast Reconstruction]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177902-cytori-therapeutics-natural-celution-for-breast-reconstruction%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Cytori Therapeutics (NASDAQ: CYTX) is a leading global innovator in the emerging field of regenerative medicine using adipose fat tissue as a rich source of adult stem cells capable of differentiating into a variety of cell types. The company develops and markets cell banking StemSource, therapeutic, and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 13 Dec 2009 12:09:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/cytori+therapeutics+inc..html"><![CDATA[Cytori Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTX</category>
		<category domain="tickers">CYTX</category>
	</item>
	<item>
		<title><![CDATA[Medicare Actuary Report Means Little in Overall Reform Context]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/10001501/medicare-actuary-report-means-little-in-overall-reform-context/]]></link>
		<description><![CDATA[Medicare actuary's report on the cost of the Senate reform bill is a tempest in a teacup. But there are serious cost problems in Senate bill and the latest proposals. by Ken Terry]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sat, 12 Dec 2009 14:36:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/actuary.html"><![CDATA[Actuary]]></category>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+senate.html"><![CDATA[U.S. Senate]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
	</item>
	<item>
		<title><![CDATA[Bristol Myers' Mead Johnson Swap: Good Deal or Smarter to Wait?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177892-bristol-myers-mead-johnson-swap-good-deal-or-smarter-to-wait%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[submits:  I was reading this Fat Pitch Financials post and saw mention of Bristol Myers Squibb BMY offering their remaining ownership of Mead Johnson Nutrition MJN in exchange for BMY shares.   Bristol Myers did a public offering of MJN earlier this year and the stock has risen...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sat, 12 Dec 2009 11:51:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/retail.html"><![CDATA[Retail]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ken+caruso.html"><![CDATA[Ken Caruso]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Good News for Dynavax HBV Vaccine]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177891-good-news-for-dynavax-hbv-vaccine%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Dynavax Technologies Corp. DVAX announced recently that it has received approval from the European Union to make part of its hepatitis B vaccine HBV Heplisav at a German factory. The EU approval permits Dynavax to commercially produce hepatitis B surface antigen, a key component of Heplisav...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sat, 12 Dec 2009 11:26:31 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/dynavax+technologies+corp..html"><![CDATA[Dynavax Technologies Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DVAX</category>
		<category domain="tickers">DVAX</category>
	</item>
	<item>
		<title><![CDATA[Gilead Closer to FDA Approval for CF Drug]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177888-gilead-closer-to-fda-approval-for-cf-drug%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Gilead Sciences, Inc GILD received a positive opinion from the Anti-Infective Drugs Advisory Committee of the US Food and Drug Administration FDA. Gilead is seeking FDA approval for inhalable aztreonam for the treatment of lung infection caused by Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sat, 12 Dec 2009 11:16:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/gilead+sciences+inc..html"><![CDATA[Gilead Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
		<category domain="tickers">GILD</category>
	</item>
	<item>
		<title><![CDATA[State Legislators Try to Preempt Federal Healthcare Reform]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/10001497/state-legislators-try-to-preempt-federal-healthcare-reform/]]></link>
		<description><![CDATA[A conservative group has prompted bills to be introduced in a dozen states that would preempt federal reform legislation, and there are suspicions that the insurance industry is behind this move. by Ken Terry]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 11 Dec 2009 15:29:54 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare+reform.html"><![CDATA[Healthcare Reform]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+insurance.html"><![CDATA[Corporate Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
	</item>
	<item>
		<title><![CDATA[Endo Pharma Gets a Setback]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177804-endo-pharma-gets-a-setback%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Endo Pharmaceuticals ENDP hit a roadblock related to the approval of Aveed. Recently, the company received a complete response letter CRL from the US Food and Drug Administration FDA regarding the New Drug Application NDA for its injectable testosterone product Aveed for men diagnosed with low...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 11 Dec 2009 08:52:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/endo+pharmaceuticals+holdings+inc..html"><![CDATA[Endo Pharmaceuticals Holdings Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ENDP</category>
		<category domain="tickers">ENDP</category>
	</item>
	<item>
		<title><![CDATA[Stryker: Prospering with Predictable Growth]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177721-stryker-prospering-with-predictable-growth%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Chuck Carnevale submits: Background Stryker SYK based in Kalamazoo, Michigan has produced one of the most consistent strings of earnings growth since 1991 of any publicly traded company. Stryker is a leading manufacturer of medical devices, primarily in orthopedics. In 2008 Orthopedic implants for hip, knee, shoulder and spine, as...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 11 Dec 2009 01:57:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/chuck+carnevale.html"><![CDATA[Chuck Carnevale]]></category>
		<category domain="http://resources.bnet.com/topic/stryker+corp..html"><![CDATA[Stryker Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
		<category domain="tickers">SYK</category>
	</item>
	<item>
		<title><![CDATA[Microsoft to buy healthcare software firm]]></title>
		<link><![CDATA[http://www.bnet.com/2448-14061_23-372825.html]]></link>
		<description><![CDATA[ Microsoft is planning to acquire health software company Sentillion for an undisclosed sum. Microsoft aims to merge Sentillion's single-sign technology with its own Amalga Unified Intelligence System to offer doctors, nurses and other healthcare workers streamlined access to patient data from a range of sources.    ...]]></description>
		<s:doctype><![CDATA[Articles]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 22:09:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/microsoft+corp..html"><![CDATA[Microsoft Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/editorial.html"><![CDATA[Editorial]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
		<category domain="tickers">MSFT</category>
	</item>
	<item>
		<title><![CDATA[Healthcare Roundup: Aetna Slammed by Senate Committee, $600M for Community Centers, Nurses Unite, NJ Court Boosts ASCs and More]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/10001491/healthcare-roundup-aetna-slammed-by-senate-committee-600m-for-community-centers-nurses-unite-nj-court-boosts-ascs-and-more/]]></link>
		<description><![CDATA[Roundup of healthcare news by Ken Terry]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 15:23:50 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/aetna+inc..html"><![CDATA[Aetna Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+senate.html"><![CDATA[U.S. Senate]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AET</category>
		<category domain="tickers">AET</category>
	</item>
	<item>
		<title><![CDATA[William Ackman Is Big on Sears, Not Retail-Sales Figures]]></title>
		<link><![CDATA[http://industry.bnet.com/retail/10005624/william-ackman-is-big-on-sears-not-retail-sales-figures/]]></link>
		<description><![CDATA[Pershing Square Capital head William Ackman is betting that lagging retail sales aren't an indicator of the industry's health as a whole. by Ian Ritter]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 14:20:47 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sears+roebuck+%2526+co..html"><![CDATA[Sears Roebuck & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/william+ackman.html"><![CDATA[William Ackman]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/ian+ritter.html"><![CDATA[Ian Ritter]]></category>
	</item>
	<item>
		<title><![CDATA[Baupost Trims Syneron Stake, Buys More Enzon]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177467-baupost-trims-syneron-stake-buys-more-enzon%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Market Folly submits: In an amended 13G just filed with the SEC, Seth Klarman's hedge fund Baupost Group has disclosed a 5.45% ownership stake in Syneron Medical ELOS. The filing was made due to activity on November 30th, 2009 and Baupost now holds 1,500,000 shares. This is a decrease from...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 12:37:32 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/market+folly.html"><![CDATA[Market Folly]]></category>
		<category domain="http://resources.bnet.com/topic/enzon+pharmaceuticals+inc..html"><![CDATA[Enzon Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ENZN</category>
		<category domain="tickers">ENZN</category>
	</item>
	<item>
		<title><![CDATA[Patent Worries Sting Eli Lilly]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177606-patent-worries-sting-eli-lilly%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[optionMONSTER submits:   By David Russell Eli Lilly LLY did the expected today, but investors were hoping for more. by optionMONSTER]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 09:54:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/optionmonster.html"><![CDATA[optionMONSTER]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">LLY</category>
	</item>
	<item>
		<title><![CDATA[Pall Corporation F1Q10 (Qtr End 10/31/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14049_23-372482.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from Brian Drab - William Blair. Brian Drab - William Blair My question is regarding the gross margin in the quarter and sustainability of the type of gross margin level. Let me just preface my question by saying that, I&#8217;ve seen...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 09:17:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/absence.html"><![CDATA[Absence]]></category>
		<category domain="http://resources.bnet.com/topic/margin.html"><![CDATA[Margin]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/william+blair+co..html"><![CDATA[William Blair Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/pall+corp..html"><![CDATA[Pall Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/life+science.html"><![CDATA[Life Science]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PLL</category>
		<category domain="tickers">PLL</category>
	</item>
	<item>
		<title><![CDATA[Eli Lilly: Solid Earnings on Deck for 2010]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177585-eli-lilly-solid-earnings-on-deck-for-2010%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eddy Elfenbein submits:  There&#8217;s good news from Eli Lilly LLY, although the market isn&#8217;t taking it that way. The company said it expects to earn $4.65 to $4.85 next year. That&#8217;s pretty good considering the stock is currently under $35. by Eddy Elfenbein]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 08:19:52 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/eddy+elfenbein.html"><![CDATA[Eddy Elfenbein]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">LLY</category>
	</item>
</channel>
</rss>
